Table 3.
Distribution of the NKG2D alleles and genotypes with regard to selected clinical parameters. Percentages calculated in regard to a total number of patients measured for a given feature.
| DAS28 at Baseline (Mean (±SD)) | CRP at Baseline (Mean (±SD)) | RF+ (Number (%)) |
CCP+ (Number (%)) |
|
|---|---|---|---|---|
| NKG2D rs1049174 | ||||
| CC | 6.58 (±0.64) | 26.36 (±35.52) | 80 (45.5%) | 101 (43.9%) |
| CG | 6.48 (±0.61) | 21.01 (±27.02) | 83 (47.2%) | 108 (47.0%) |
| GG | 6.67 (±0.58) | 33.04 (±64.81) | 13 (7.4%) | 21 (9.1%) |
| NKG2D rs1154831 | ||||
| AA | 6.59 (±0.53) | 24.54 (±18.31) | 4 (2.3%) | 5 (2.2%) |
| AC | 6.57 (±0.65) | 18.14 (±18.19) | 57 (32.4%) | 68 (29.6%) |
| CC | 6.52 (±0.62) | 27.33 (±41.55) | 115 (65.3%) | 157 (68.3%) |
| NKG2D rs2255336 | ||||
| AA | 6.85 (±0.61) | 37.14 (±56.51) | 6 (3.4%) | 7 (3.0%) |
| AG | 6.50 (±0.57) | 24.09 (±36.97) | 60 (34.1%) | 77 (33.5%) |
| GG | 6.53 (±0.65) | 23.69 (±32.91) | 110 (62.5%) | 146 (63.5%) |